E. Galíndez-Agirregoikoa

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 109 citations · Full text

Life Sciences, Pharmacotherapy, Surgery +6

Efficacy of Anakinra in Refractory Adult-Onset Still's Disease

F. Ortíz-Sanjuán, Ricardo Blanco, Leyre Riancho‐Zarrabeitia et al. · Medicine · 2015 · 101 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +8

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · PubMed · 2020 · 34 citations

Medicine, Internal Medicine, Pharmacotherapy +11

The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis

D. Prieto-Peña, Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals et al. · Clinical and Experimental Rheumatology · 2021 · 26 citations · Full text

Life Sciences, Immunology, Neurology +12

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

J. Loricera, Santos Castañeda, C. Moriano et al. · Therapeutic Advances in Musculoskeletal Disease · 2022 · 26 citations · Full text

Medicine, Neurology, Ophthalmology +10